PTC Therapeutics Stock Price - PTCT

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 43.69 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
PTC Therapeutics Inc PTCT NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.97 2.27% 43.69 43.905 42.76 43.03 42.72 23:59:43
Bid Price Ask Price Spread Spread % News
10.00 49.87 39.87 79.95% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,939 412,803 $ 43.52 $ 17,964,755 671,551 27.53 - 49.00
Last Trade Time Type Quantity Stock Price Currency
17:41:49 formt 13,518 $ 43.69 USD

PTC Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.69B 61.63M $ -128.08M -2.72 -13.59 61.23M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 0.70%

more financials information »

PTC Therapeutics News

Loading Messages....

Latest PTCT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PTCT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week40.0049.0039.5241.84661,7383.699.22%
1 Month36.5549.0036.1240.22713,6017.1419.53%
3 Months45.0049.0031.4938.44701,262-1.31-2.91%
6 Months38.9749.0031.4940.41594,8074.7212.11%
1 Year31.6549.0027.5337.03678,74212.0438.04%
3 Years11.9652.957.9826.98886,80731.73265.3%
5 Years39.0378.724.0324.411,006,9314.6611.94%

PTC Therapeutics Description

PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.

Your Recent History
PTC Therap..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.